Clorox (NYSE:CLX) Price Target Raised to $140.00 at Barclays

Clorox (NYSE:CLX) had its price target upped by Barclays from $130.00 to $140.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s target price suggests a potential downside of 5.11% from the company’s current price.

A number of other equities research analysts also recently weighed in on CLX. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Wells Fargo & Company raised their price objective on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday. Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a research report on Tuesday. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday. Finally, JPMorgan Chase & Co. raised their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $158.21.

Clorox Stock Performance

Shares of Clorox stock opened at $147.55 on Wednesday. The firm has a market cap of $18.26 billion, a P/E ratio of 51.41, a P/E/G ratio of 2.92 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. Clorox has a 12 month low of $127.60 and a 12 month high of $171.37. The stock’s fifty day moving average price is $161.83 and its 200-day moving average price is $158.67.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.08% and a net margin of 4.78%. During the same quarter last year, the company earned $2.16 EPS. On average, equities research analysts expect that Clorox will post 6.86 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CLX. Mizuho Securities USA LLC raised its stake in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Ilex Capital Partners UK LLP raised its position in Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after acquiring an additional 453,624 shares in the last quarter. International Assets Investment Management LLC raised its position in Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after acquiring an additional 435,971 shares in the last quarter. Boston Trust Walden Corp raised its position in Clorox by 5,442.5% during the third quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock valued at $44,622,000 after acquiring an additional 268,966 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its position in Clorox by 302.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company’s stock valued at $57,390,000 after acquiring an additional 265,455 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.